Effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide fumarate for people with ultra-high viral load of HIV-1: a retrospective real-world cohort study

BackgroundThis study evaluated the effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) in treatment-naïve adults with HIV-1 and an ultra-high viral load (uVL; HIV-1 RNA ≥500,000 copies/mL)—a population at high risk for suboptimal outcomes.MethodsA retrospective...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Xiangxi He, Xiaoxin Xie, Yanhua Fu, Jinhong He, Xingxing Luo, Hai Long
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Frontiers Media S.A. 2025-11-01
Ráidu:	Frontiers in Virology
Fáttát:	bictegravir/emtricitabine/tenofovir alafenamide fumarate HIV/AIDS ultra-high viral load efficacy safety
Liŋkkat:	https://www.frontiersin.org/articles/10.3389/fviro.2025.1653276/full
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!